TRIAL DETAIL

Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors

Drug:
Trial Name:
Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors
NCT#:
Conditions:
Gastrointestinal Stromal Tumor
Status:
Withdrawn
Phase:
1
Start Date 11/30/2014
Age of Trial (yrs) 7.6
Treatment Phase:
Gleevec-resistant
Drug Category:
KIT/PDGFRA inhibitor+ VEGF inhibitor (TKI)
Strategy:
Block KIT + Block blood vessel growth
Trial Type:
Specifically GIST and only GIST
Other Protocol IDs:
AMC1401
Sponsor:
Asan Medical Center
Patient Contact:
Min-Hee Ryu, PhD 82-2-3010-5935 miniryu@amc.seoul.kr
Contact email:
Contact Phone:
Randomized:
IV or Oral:
Oral
Trial Notes:

Trial Links

Trial Results

Drug Information

Trial Sites

Name
Address
City
State
Zip
Country
Seoul
Songpa-gu
138-736
Republic of Korea